Procaps Group, S.A Net Profit Margin 2020-2023 | PROCF
Procaps Group, S.A net profit margin from 2020 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Procaps Group, S.A Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2023-09-30 |
$0.41B |
$0.05B |
12.59% |
| 2023-06-30 |
$0.41B |
$0.07B |
16.54% |
| 2023-03-31 |
$0.41B |
$0.03B |
8.11% |
| 2022-12-31 |
$0.41B |
$0.04B |
10.27% |
| 2022-09-30 |
$0.44B |
$0.06B |
13.79% |
| 2022-06-30 |
$0.43B |
$-0.07B |
-17.13% |
| 2022-03-31 |
$0.42B |
$-0.07B |
-16.23% |
| 2021-12-31 |
$0.41B |
$-0.10B |
-24.63% |
| 2021-09-30 |
$0.54B |
$-0.14B |
-25.23% |
| 2021-06-30 |
$0.51B |
$-0.03B |
-4.93% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
